Preliminary Study on the Efficacy and Mechanism of Hydroxytyrosol-Nicotinamide in the Treatment of Premature Ovarian Insufficiency
To determine whether HT-NIC can attenuate chemotherapy-induced ovarian failure through antioxidant effects, cellular senescence, and DNA-repair fidelity, and provide new insights for the diagnosis and therapy of POI